These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 7544236

  • 1. Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan.
    Larivière R, Sventek P, Thibault G, Schiffrin EL.
    Can J Physiol Pharmacol; 1995 Mar; 73(3):390-8. PubMed ID: 7544236
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.
    Schiffrin EL, Sventek P, Li JS, Turgeon A, Reudelhuber T.
    Br J Pharmacol; 1995 Aug; 115(8):1377-81. PubMed ID: 8564194
    [Abstract] [Full Text] [Related]

  • 3. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure.
    Schiffrin EL, Larivière R, Li JS, Sventek P.
    J Vasc Res; 1996 Aug; 33(3):235-48. PubMed ID: 8924521
    [Abstract] [Full Text] [Related]

  • 4. Endothelin-1 gene expression and vascular hypertrophy in DOCA-salt hypertension compared to spontaneously hypertensive rats.
    Schiffrin EL, Lariviere R, Li JS, Sventek P, Touyz RM.
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S188-90. PubMed ID: 9072349
    [Abstract] [Full Text] [Related]

  • 5. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.
    Li JS, Larivière R, Schiffrin EL.
    Hypertension; 1994 Aug; 24(2):183-8. PubMed ID: 8039842
    [Abstract] [Full Text] [Related]

  • 6. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy.
    Schiffrin EL, Larivière R, Li JS, Sventek P, Touyz RM.
    J Cardiovasc Pharmacol; 1995 Aug; 26 Suppl 3():S5-8. PubMed ID: 8587458
    [Abstract] [Full Text] [Related]

  • 7. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL, Turgeon A, Deng LY.
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [Abstract] [Full Text] [Related]

  • 8. Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats.
    Larivière R, Day R, Schiffrin EL.
    Hypertension; 1993 Jun; 21(6 Pt 2):916-20. PubMed ID: 8505101
    [Abstract] [Full Text] [Related]

  • 9. Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats.
    Li JS, Schürch W, Schiffrin EL.
    Am J Hypertens; 1996 Aug; 9(8):803-11. PubMed ID: 8862227
    [Abstract] [Full Text] [Related]

  • 10. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS, Turgeon A, Schiffrin EL.
    Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
    [Abstract] [Full Text] [Related]

  • 11. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
    Fujita K, Matsumura Y, Miyazaki Y, Hashimoto N, Takaoka M, Morimoto S.
    Life Sci; 1996 May; 58(1):PL1-7. PubMed ID: 8628104
    [Abstract] [Full Text] [Related]

  • 12. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats.
    Larivière R, Thibault G, Schiffrin EL.
    Hypertension; 1993 Mar; 21(3):294-300. PubMed ID: 8478038
    [Abstract] [Full Text] [Related]

  • 13. Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension.
    Fujita K, Matsumura Y, Kita S, Miyazaki Y, Hisaki K, Takaoka M, Morimoto S.
    Br J Pharmacol; 1995 Mar; 114(5):925-30. PubMed ID: 7780646
    [Abstract] [Full Text] [Related]

  • 14. Effects of the endothelin ETA-receptor antagonist FR139317 on development of hypertension and cardiovascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
    Fujita K, Matsumura Y, Miyazaki Y, Takaoka M, Morimoto S.
    Jpn J Pharmacol; 1996 Apr; 70(4):313-9. PubMed ID: 8774759
    [Abstract] [Full Text] [Related]

  • 15. Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats.
    David FL, Carvalho MH, Cobra AL, Nigro D, Fortes ZB, Rebouças NA, Tostes RC.
    Hypertension; 2001 Sep; 38(3 Pt 2):692-6. PubMed ID: 11566958
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M, Gopalakrishnan V, McNeill JR.
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Apoptosis in aorta of deoxycorticosterone acetate-salt hypertensive rats: effect of endothelin receptor antagonism.
    Sharifi AM, Schiffrin EL.
    J Hypertens; 1997 Dec; 15(12 Pt 1):1441-8. PubMed ID: 9431850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.